#$%^&*AU2012100335B420120503.pdf#####ABSTRACT A method is provided for administering to a mammal suffering from, or at risk for, an intraocular neovascular disorder with regular dosing of a therapeutically effective amount of VEGF antagonist, followed by less frequent dosing of a therapeutically 5 effective amount of VEGF antagonist. 3247003_1 (GHMatters) P71763.AU.8 26-Mar-12